Background: It takes many years to obtain reliable values for the risk of venous thrombosis of
hormonal contraceptive users from clinical data. Measurement of activated protein C (APC) …

Objective: We determined whether reported intake of oral contraceptives is associated with
an acute phase response, since inflammation is important in atherogenesis and may …

Background: Oral contraceptives (OC) containing different types of progestogens induce
different sensitivities to activated protein C (APC) measured with the thrombin generation …

The use of oral contraceptives is a well-established acquired risk factor for venous
thrombosis. In 1995, a number of epidemiological studies were published which suggested …

OBJECTIVE: To evaluate the effect of third-generation oral contraceptives on high-sensitivity
C-reactive protein (CRP), homocysteine, and lipids levels in a population of young, fertile …

Ovarian cancer incidence has declined in recent decades, due in part to oral contraceptive
(OC) use and tubal ligation. However, intrauterine device (IUD) use has increasingly …

Objectives The risk of venous thromboembolism (VTE) is highest during the initial months of
oral contraceptive (OC) use. We sought to evaluate the extent of hemostatic variable …

The aim of the study was to determine the effect of combined oral contraceptive (COC) on
the coagulation system in healthy Albanian women. The study included 28 women between …

The use of COCs, even low-and microdosed should be based on an individual assessment
of the risk of thrombotic complications. It is advisable to combine the COC together with …

Background Venous thromboembolism (VTE) is associated with excessive coagulation
activity, which in part can be attributed to activation of contact system. However, the …